Compare ATAI & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATAI | INTA |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2025 | 2021 |
| Metric | ATAI | INTA |
|---|---|---|
| Price | $7.21 | $37.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $15.88 | ★ $41.43 |
| AVG Volume (30 Days) | ★ 17.7M | 800.4K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.89 |
| EPS | ★ N/A | N/A |
| Revenue | $4,089,000.00 | ★ $504,120,000.00 |
| Revenue This Year | N/A | $15.91 |
| Revenue Next Year | N/A | $13.78 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1227.60 | 17.09 |
| 52 Week Low | $3.27 | $19.01 |
| 52 Week High | $7.22 | $47.93 |
| Indicator | ATAI | INTA |
|---|---|---|
| Relative Strength Index (RSI) | 72.28 | 74.52 |
| Support Level | $3.89 | $36.00 |
| Resistance Level | N/A | $40.30 |
| Average True Range (ATR) | 0.05 | 1.80 |
| MACD | -0.06 | 0.63 |
| Stochastic Oscillator | 75.00 | 90.60 |
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.